GLAUKOS Corp (GKOS) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 58.73M; Formula and calculation Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 58.73M | Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-04-30. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 58.73M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-03-31 | 58.73M | (m) | (m) |
| 2025-09-30 | 57.43M | (m) | (m) |
| 2025-06-30 | 57.35M | (m) | (m) |
| 2025-03-31 | 57.14M | (m) | (m) |
| 2024-09-30 | 55.14M | (m) | (m) |
| 2024-06-30 | 54.95M | (m) | (m) |
| 2024-03-31 | 50.37M | (m) | (m) |
| 2023-09-30 | 48.80M | (m) | (m) |
| 2023-06-30 | 48.65M | (m) | (m) |
| 2023-03-31 | 48.21M | (m) | (m) |
| 2022-09-30 | 47.70M | (m) | (m) |
| 2022-06-30 | 47.60M | (m) | (m) |
| 2022-03-31 | 47.33M | (m) | (m) |
| 2021-12-31 | 47.05M | (m) | (m) |
| 2021-09-30 | 46.89M | (m) | (m) |
| 2021-06-30 | 46.56M | (m) | (m) |
| 2021-03-31 | 46.28M | (m) | (m) |
| 2020-12-31 | 45.79M | (m) | (m) |
| 2020-09-30 | 44.96M | (m) | (m) |
| 2020-06-30 | 44.67M | (m) | (m) |
| 2020-03-31 | 44.23M | (m) | (m) |
| 2019-12-31 | 43.74M | (m) | (m) |
| 2019-09-30 | 36.93M | (m) | (m) |
| 2019-06-30 | 36.83M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |